260 filings
DEF 14A
ETON
Eton Pharmaceuticals Inc
Definitive proxy
26 Apr 24
4:21pm
8-K
ETON
Eton Pharmaceuticals Inc
18 Apr 24
Unregistered Sales of Equity Securities
4:22pm
S-8
ETON
Eton Pharmaceuticals Inc
26 Mar 24
Registration of securities for employees
4:24pm
10-K/A
2023 FY
ETON
Eton Pharmaceuticals Inc
Annual report (amended)
22 Mar 24
4:17pm
8-K
ETON
Eton Pharmaceuticals Inc
22 Mar 24
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKEĀ® for Phenylketonuria
6:55am
8-K
uer77249
14 Mar 24
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
4:16pm
8-K
1dnc5hjfmg umf6meu
21 Feb 24
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
6:55am
4
96yt3ofaw9j cfpfdho
15 Feb 24
Eton Pharmaceuticals / James R. Gruber ownership change
4:21pm
4
2l4c 5nvo
15 Feb 24
Eton Pharmaceuticals / Jennifer McKie Adams ownership change
4:19pm
4
mgui9e7ka76x2b sx
15 Feb 24
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:19pm
4
kwp4 2fg103
15 Feb 24
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:18pm
4
k4xirw7 jq00i53jp6hs
15 Feb 24
Eton Pharmaceuticals / David Krempa ownership change
4:17pm
4
k7km9p
15 Feb 24
Eton Pharmaceuticals / PAUL V MAIER ownership change
4:16pm
4
ljpit211p309on8bet
15 Feb 24
Eton Pharmaceuticals / NORBERT G RIEDEL ownership change
4:15pm
SC 13G/A
xgcdb0yggng4ut5tu3
9 Feb 24
Eton Pharmaceuticals / Opaleye Management ownership change
4:05pm
8-K
hegonmmrwga928f5stu
2 Feb 24
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
6:55am
8-K
gn9lql 93
9 Nov 23
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
12:00am
8-K
eoa1vbju
4 Oct 23
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
6:55am